Working to Eradicate Gynecologic Cancers

Jose Alejandro Rauh-Hain, MD

Fellow
Massachusetts General Hospital/Harvard University
55 Fruit St.
Yawkey Building, Suite 9-E
Boston, MA
USA 02114

Papers:
74 Recent trends in the utilization of lymphadenectomy among patients undergoing surgery for endometrioid adenocarcinoma of the endometrium: an analysis of the Surveillance, Epidemiology, and End Results database, 1998-2010 81 The impact of adjuvant therapy on survival in uterine clear cell carcinoma patients 111 Racial disparities in treatment of high grade endometrial cancer in the Medicare population 189 The impact of body mass index on intraperitoneal chemotherapy outcomes 219 Trends in Treatment of Uterine Serous Cancer in the Medicare Population 224 Impact of venous thromboembolism on mortality of elderly medicare patients with epithelial endometrial cancer 241 Comparing vaginal sarcoma and carcinoma in the Surveillance, Epidemiology and End Results program, 1988 to 2010: an analysis of 4,062 patients 269 Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared to fallopian tube cancer 392 Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition 406 Comparing the natural history and survival of vulvar sarcoma and squamous cell carcinoma: an analysis 11,677 cases in the Surveillance, Epidemiology, and End Results database 407 The role of endometrial biopsy in the preoperative detection of uterine leiomyosarcoma 408 Trends in the treatment of uterine leiomyosarcoma in the Medicare population 409 Gynecologic oncologist as surgical consultant: intraoperative consultations during general gynecologic surgery as an important focus of gynecologic oncology training 424 Comparing survival of vulvar melanoma and squamous cell carcinoma: an analysis of 13,112 patients in the Surveillance, Epidemiology and End Results database